Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
SUPN [NASD]
Supernus Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-2.09 Insider Own1.90% Shs Outstand30.88M Perf Week1.98%
Market Cap207.17M Forward P/E- EPS next Y-0.82 Insider Trans-47.09% Shs Float29.22M Perf Month7.19%
Income-55.70M PEG- EPS next Q-0.67 Inst Own89.40% Short Float11.17% Perf Quarter22.00%
Sales1.40M P/S147.98 EPS this Y-145.00% Inst Trans5.71% Short Ratio5.52 Perf Half Y-2.89%
Book/sh1.34 P/B5.01 EPS next Y66.90% ROA-69.60% Target Price11.00 Perf Year33.93%
Cash/sh2.26 P/C2.96 EPS next 5Y- ROE-138.00% 52W Range4.45 - 16.68 Perf YTD-6.42%
Dividend- P/FCF- EPS past 5Y-25.60% ROI-108.20% 52W High-59.77% Beta-
Dividend %- Quick Ratio2.70 Sales past 5Y-18.60% Gross Margin- 52W Low50.79% ATR0.32
Employees110 Current Ratio2.80 Sales Q/Q-50.00% Oper. Margin- RSI (14)57.91 Volatility3.94% 4.79%
OptionableYes Debt/Eq0.49 EPS Q/Q-42.90% Profit Margin- Rel Volume0.26 Prev Close6.67
ShortableYes LT Debt/Eq0.19 EarningsMay 13 AMC Payout- Avg Volume591.48K Price6.71
Recom1.80 SMA20-0.64% SMA5014.27% SMA200-19.37% Volume153,932 Change0.60%
29-May-12Initiated Stifel Nicolaus Buy $15
19-Jun-13 09:29AM  Wednesday's Small Cap Biotech Catalyst Watch And Trade List at Seeking Alpha
12-Jun-13 09:16AM  SUPERNUS PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
11-Jun-13 04:05PM  Tentative Approval for SUPN Candidate Zacks
10-Jun-13 09:06AM  InPlay: Supernus Pharma receives tentative approval for Trokendi XR Briefing.com
09:00AM  Supernus Receives Tentative Approval for Trokendi XR(TM) GlobeNewswire
21-May-13 01:04PM  SUPERNUS PHARMACEUTICALS INC Financials EDGAR Online Financials
20-May-13 04:30PM  Supernus to Present at Two Investor Conferences GlobeNewswire
10:00AM  SUPERNUS PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
17-May-13 01:47PM  5 Stocks Setting Up to Break Out at TheStreet
15-May-13 09:19AM  SUPERNUS PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report EDGAR Online
14-May-13 11:53PM  8 Stocks Under $10 Trending Sharply Higher at TheStreet +5.27%
09:40AM  Narrower-than-Expected Loss at Supernus Zacks
13-May-13 04:08PM  InPlay: Supernus Pharma beats by $0.08 Briefing.com
04:00PM  Supernus Pharmaceuticals Reports First Quarter 2013 Financial Results GlobeNewswire
09:47AM  SUPERNUS PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements EDGAR Online
07:07AM  Q1 2013 Supernus Pharmaceuticals Earnings Release - After Market Close CCBN
09-May-13 10:03AM  SUPERNUS PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Fin EDGAR Online
06-May-13 04:30PM  Supernus Announces First Quarter 2013 Earnings Conference Call and Webcast GlobeNewswire
10:31AM  SUPERNUS PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
08:00AM  Supernus Announces Closing of $90 Million of 7.50% Convertible Senior Secured Notes Due 2019 GlobeNewswire
05-May-13 07:55AM  Supernus Secures Financing For CNS Pipeline Development at Seeking Alpha
02-May-13 11:28AM  Generic Drug Pricing Pressure Remains in Western Europe, While Central and Eastern Europe, Latin America and Parts of Asia Eye Fairly Strong Growth in Generic Drugs Wall Street Transcript
29-Apr-13 03:14AM  Supernus rebounds with call buying optionMONSTER
02:53AM  Supernus rebounds with call buying optionMONSTER
02:23AM  Supernus rebounds with call buying optionMONSTER
26-Apr-13 09:01AM  InPlay: Supernus Pharma Prices Offering of $75 Million of 7.50% Convertible Senior Secured Notes Due 2019 Briefing.com +9.76%
09:00AM  Supernus Prices Offering of $75 Million of 7.50% Convertible Senior Secured Notes Due 2019 GlobeNewswire
07:55AM  SUPERNUS PHARMACEUTICALS INC Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial Statements and Exh EDGAR Online
06:29AM  SUPERNUS PHARMACEUTICALS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders, Other Events, F EDGAR Online
24-Apr-13 04:15PM  InPlay: Supernus Pharma announces proposed offering of $75 mln of Convertible Senior Secured Notes due 2019 Briefing.com
04:15PM  Supernus Announces Proposed Offering of $75 Million of Convertible Senior Secured Notes GlobeNewswire
22-Apr-13 12:37PM  Supernus Pharmaceuticals Enters Oversold Territory (SUPN) at TheStreet
08-Apr-13 06:03PM  Nasdaq stocks posting largest percentage increases AP
01:17PM  Nasdaq stocks posting largest percentage increases AP
11:03AM  Small Pharma Watch List: Week Of April 8, 2013 at Seeking Alpha
05-Apr-13 06:09PM  Nasdaq stocks posting largest percentage increases AP +7.71%
26-Mar-13 04:36PM  InPlay: Supernus Pharma Director discloses buying 35K shares at $5.11-5.68 on 3/20-3/22, worth ~$200K Briefing.com -5.44%
10:48AM  Supernus: Record For Worst Launch In Recent History? at Seeking Alpha
25-Mar-13 08:03PM  United Therapeutics Can't Stop Getting Rejected at Motley Fool
21-Mar-13 03:43PM  Rockwell May Rise On Positive Phase III Results In July at Seeking Alpha
01:17PM  Nasdaq stocks posting largest percentage increases AP
01:04PM  SUPERNUS PHARMACEUTICALS INC Financials EDGAR Online Financials
20-Mar-13 06:06PM  Nasdaq stocks posting largest percentage increases AP +10.22%
19-Mar-13 01:17PM  Nasdaq stocks posting largest percentage decreases AP
18-Mar-13 06:02PM  Nasdaq stocks posting largest percentage decreases AP -9.75%
01:17PM  Nasdaq stocks posting largest percentage decreases AP
16-Mar-13 07:31PM  New Star Analyst Rankings for Supernus Pharmaceuticals, Inc. StarMine
15-Mar-13 07:40PM  New Star Analyst Rankings for Supernus Pharmaceuticals, Inc. StarMine -19.71%
06:02PM  Nasdaq stocks posting largest percentage decreases AP
04:21PM  SUPERNUS PHARMACEUTICALS INC Files SEC form 10-K, Annual Report EDGAR Online
03:38PM  Loss Narrows at Supernus Zacks
14-Mar-13 07:07PM  Supernus Pharmaceuticals' CEO Discusses Q4 2012 Results - Earnings Call Transcript at Seeking Alpha
04:31PM  SUPERNUS PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements EDGAR Online
04:01PM  Supernus Pharmaceuticals Reports Fourth Quarter 2012 and Full Year 2012 Financial Results GlobeNewswire
07:07AM  Q4 2012 Supernus Pharmaceuticals Earnings Release - After Market Close CCBN
11-Mar-13 05:01PM  SUPERNUS PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
07-Mar-13 09:08PM  Supernus Announces Year-End and Fourth Quarter 2012 Earnings Conference Call and Webcast GlobeNewswire
08-Feb-13 03:43PM  Supernus' Update on Oxtellar Zacks
07-Feb-13 05:01PM  SUPERNUS PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial EDGAR Online
05-Feb-13 05:38PM  Oxtellar XR Launched by Supernus Zacks
01-Feb-13 08:00AM  Supernus Launches Oxtellar XR(TM) in the United States GlobeNewswire
24-Jan-13 12:36PM  5 Stocks Under $10 Poised to Pop at TheStreet
22-Jan-13 12:16PM  Small Pharma Watch List: Week Of January 21st at Seeking Alpha +5.17%
17-Jan-13 06:01AM  SUPERNUS PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, Financial S EDGAR Online
16-Jan-13 01:56AM  Supernus Pharmaceuticals Readying For A Super Year Ahead at Seeking Alpha
14-Jan-13 07:30PM  Supernus Appoints Victor Vaughn as Senior Vice President of Sales GlobeNewswire
21-Dec-12 10:18AM  Recent Small Pharma Offerings Create Tempting Current Entries at Seeking Alpha
18-Dec-12 06:04PM  Nasdaq stocks posting largest percentage decreases AP +6.95%
01:27PM  Nasdaq stocks posting largest percentage decreases AP
17-Dec-12 06:02PM  Nasdaq stocks posting largest percentage decreases AP -6.75%
01:22PM  Nasdaq stocks posting largest percentage decreases AP
13-Dec-12 12:44PM  Arena Pressures Short Sellers as Hedge Fund Owner Pressures Vivus at Motley Fool -7.58%
07-Dec-12 10:44AM  Do Oxtellar and Trokendi Make Supernas a Buy? at Motley Fool
06:52AM  Favorable AcelRx Stock Offering Price May Catalyze The Company's Share Price at Seeking Alpha
06-Dec-12 02:42PM  Why Supernus Lost in November at Motley Fool
02:33PM  ACRX Falls On Financing, Creating Opportunity Ahead Of Phase III Data at Seeking Alpha
04-Dec-12 02:54PM  Small Pharmaceuticals With Near Term Catalysts Offer Investment Opportunities at Seeking Alpha
01:25PM  Nasdaq stocks posting largest percentage decreases AP
03-Dec-12 06:03PM  Nasdaq stocks posting largest volume increases AP
06:02PM  Nasdaq stocks posting largest percentage decreases AP
01:36PM  Nasdaq stocks posting largest percentage decreases AP
02-Dec-12 11:09PM  3 Horrendous Health-Care Stocks This Week at Motley Fool
30-Nov-12 06:33PM  Supernus' Shocking Dilution at Motley Fool -18.72%
06:03PM  Nasdaq stocks posting largest volume increases AP
06:03PM  Nasdaq stocks posting largest percentage decreases AP
01:20PM  Nasdaq stocks posting largest percentage decreases AP
12:11PM  Fridays biggest movers; Zynga down after divorce at MarketWatch
10:17AM  Supernus Pharma stock tumbles on sale of 6M shares AP
09:57AM  Supernus Pharma stock tumbles on sale of 6M shares AP
08:47AM  Fridays biggest gaining and declining stocks at MarketWatch
29-Nov-12 11:49PM  Supernus Announces Pricing of Public Offering GlobeNewswire -10.31%
06:03PM  Nasdaq stocks posting largest percentage decreases AP
01:34PM  Nasdaq stocks posting largest percentage decreases AP
28-Nov-12 06:14PM  Analyst says Supernus shares are at a fair price AP
27-Nov-12 06:04PM  Nasdaq stocks posting largest percentage decreases AP
01:20PM  Nasdaq stocks posting largest percentage decreases AP
09:36AM  Supernus Pharmaceuticals initiated with a Neutral at Citigroup theflyonthewall.com
26-Nov-12 06:18PM  Nasdaq stocks posting largest percentage decreases AP -5.48%
06:14PM  Pipeline Advances at Supernus Zacks
06:56AM  After Two Drug Approvals, Can Supernus Deliver In 2013? at Seeking Alpha
Supernus Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing products for the treatment of central nervous system diseases. Its products include SPN-538, an extended release topiramate product that completed clinical trials in support of new drug application for the treatment of epilepsy; Epliga, an extended release oxcarbazepine, which is in Phase III clinical trials targeting epilepsy; SPN-810, a molindone hydrochloride that is in Phase II clinical trials for treatment for impulsive aggression in patients with attention deficit hyperactivity disorder; and SPN-812, a Phase II clinical trial product targeting attention deficit hyperactivity disorder. The company also develops SPN-809, which has an open investigational new drug application for the treatment of depression. It intends to market its products to specialty physicians, including neurologists and psychiatrists in the United States. The company was founded in 2005 and is based in Rockville, Maryland.